Loading the section…

QGEN: financial statements from SEC — TradeAlmanac

QGEN

Qiagen N.V.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/12/2025	31/12/2024	31/12/2023	31/12/2022
Revenue	2.09B	1.98B	1.97B	2.14B
Cost of revenue	791M	1.01B	732M	757M
Gross profit	1.30B	967M	1.23B	1.38B
Selling, general and administrative	126M	113M	119M	130M
Operating expenses	834M	870M	824M	853M
Operating income	466M	98M	410M	531M
Pre-tax income	490M	121M	430M	513M
Income tax	65M	38M	89M	89M
Net income	425M	84M	341M	423M
Earnings per share	1.96	0.38	1.50	1.86
Earnings per share, diluted	1.94	0.37	1.48	1.84
Weighted average shares	217M	223M	228M	228M
Weighted average shares, diluted	219M	225M	231M	230M

Balance sheet

Metric	18/08/2026	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021
Cash and equivalents	—	839M	664M	668M	731M	881M
Short-term investments	—	260M	489M	390M	—

Cash flow

Metric	31/12/2025	31/12/2024	31/12/2023	31/12/2022
Operating cash flow	654M	674M	459M	715M
Depreciation and amortisation	194M	203M	205M	208M
Share-based compensation	50M	44M	47M	50M
Capital expenditure

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator